Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Hematologic Diseases"" wg kryterium: Temat


Tytuł :
Diagnosis of a difficult to differentiate case of early-onset hyperviscosity syndrome caused by IgM type multiple myeloma: a case report.
Autorzy :
Yoshimura T; Department of Hematology, Osaka City General Hospital, 2-13-22, Miyakojima-hondori, Miyakojima-ku, Osaka, Osaka, 534-0021, Japan. .
Hayashi Y; Department of Hematology, Osaka City General Hospital, 2-13-22, Miyakojima-hondori, Miyakojima-ku, Osaka, Osaka, 534-0021, Japan.
Shimizu K; Department of Hematology, Osaka City General Hospital, 2-13-22, Miyakojima-hondori, Miyakojima-ku, Osaka, Osaka, 534-0021, Japan.
Yagi N; Department of Hematology, Osaka City General Hospital, 2-13-22, Miyakojima-hondori, Miyakojima-ku, Osaka, Osaka, 534-0021, Japan.
Tsutsumi M; Department of Hematology, Osaka City General Hospital, 2-13-22, Miyakojima-hondori, Miyakojima-ku, Osaka, Osaka, 534-0021, Japan.
Nakaya Y; Department of Hematology, Osaka City General Hospital, 2-13-22, Miyakojima-hondori, Miyakojima-ku, Osaka, Osaka, 534-0021, Japan.
Fuseya H; Department of Hematology, Osaka City General Hospital, 2-13-22, Miyakojima-hondori, Miyakojima-ku, Osaka, Osaka, 534-0021, Japan.
Horiuchi M; Department of Hematology, Osaka City General Hospital, 2-13-22, Miyakojima-hondori, Miyakojima-ku, Osaka, Osaka, 534-0021, Japan.
Yoshida M; Department of Hematology, Osaka City General Hospital, 2-13-22, Miyakojima-hondori, Miyakojima-ku, Osaka, Osaka, 534-0021, Japan.
Nakao T; Department of Hematology, Osaka City General Hospital, 2-13-22, Miyakojima-hondori, Miyakojima-ku, Osaka, Osaka, 534-0021, Japan.
Inoue T; Department of Pathology, Osaka City General Hospital, Osaka, Japan.
Yamane T; Department of Hematology, Osaka City General Hospital, 2-13-22, Miyakojima-hondori, Miyakojima-ku, Osaka, Osaka, 534-0021, Japan.
Pokaż więcej
Źródło :
International journal of hematology [Int J Hematol] 2020 Nov; Vol. 112 (5), pp. 741-745. Date of Electronic Publication: 2020 Jun 22.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Blood Viscosity*
Immunoglobulin M*
Myeloma Proteins*
Hematologic Diseases/*diagnosis
Hematologic Diseases/*etiology
Multiple Myeloma/*complications
Adult ; Age of Onset ; Diagnosis, Differential ; Hematologic Diseases/blood ; Hematologic Diseases/therapy ; Hematopoietic Stem Cell Transplantation ; Humans ; Male ; Oligopeptides/therapeutic use ; Syndrome ; Transplantation, Autologous ; Treatment Outcome ; Waldenstrom Macroglobulinemia
Czasopismo naukowe
Tytuł :
Liquid biopsy technologies for hematological diseases.
Autorzy :
Fu Y; Department of Biomedical Engineering, City University of Hong Kong, Kowloon Tong, Hong Kong, China.
Zhang Y; Department of Biomedical Engineering, City University of Hong Kong, Kowloon Tong, Hong Kong, China.
Khoo BL; Department of Biomedical Engineering, City University of Hong Kong, Kowloon Tong, Hong Kong, China.
Pokaż więcej
Źródło :
Medicinal research reviews [Med Res Rev] 2021 Jan; Vol. 41 (1), pp. 246-274. Date of Electronic Publication: 2020 Sep 14.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms :
Biomedical Technology*
Liquid Biopsy*
Hematologic Diseases/*diagnosis
Hematologic Diseases/*pathology
Biomarkers/metabolism ; COVID-19/diagnosis ; Hematologic Diseases/blood ; Humans ; Microfluidics
Czasopismo naukowe
Tytuł :
Hematologic Consequences of the Coronavirus Crisis-Focus on Relevant Clues and Complications for the Perioperative Cardiothoracic and Vascular Community.
Autorzy :
Thalji NK; Cardiovascular and Thoracic Division, Department of Anesthesiology and Critical Care, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
Patel PA; Cardiovascular and Thoracic Division, Department of Anesthesiology and Critical Care, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
Elliott M; Critical Care Medicine Division, Department of Anesthesiology and Critical Care, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
Augoustides JG; Cardiovascular and Thoracic Division, Department of Anesthesiology and Critical Care, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA. Electronic address: .
Pokaż więcej
Źródło :
Journal of cardiothoracic and vascular anesthesia [J Cardiothorac Vasc Anesth] 2020 Dec; Vol. 34 (12), pp. 3189-3192. Date of Electronic Publication: 2020 May 27.
Typ publikacji :
Editorial
MeSH Terms :
Anesthesia, Cardiac Procedures/*standards
COVID-19/*therapy
Cardiac Surgical Procedures/*standards
Hematologic Diseases/*therapy
Perioperative Care/*standards
Blood Cell Count/standards ; Blood Coagulation/physiology ; COVID-19/epidemiology ; Hematologic Diseases/blood ; Hematologic Diseases/epidemiology ; Humans
Opinia redakcyjna
Tytuł :
How we have protected our patients: The Italian pediatric onco-hematology units' response to the COVID-19 pandemic.
Autorzy :
Amicucci M; Onco-Hematology and Cell and Gene Therapy Department, Ospedale Pediatrico Bambino Gesu, Rome, Italy.
Canesi M; Pediatric Hematology and Oncology Unit, Fondazione Monza e Brianza per il Bambino e la sua Mamma, Monza, Italy.
Rostagno E; Pediatric Onco-Hematology Unit, Università degli Studi di Bologna, Azienda Ospedaliera di Bologna Policlinico Sant'Orsola-Malpighi, Bologna, Italy.
Bergadano A; Pediatric Hematology and Oncology Stem Cell Transplantation and Cellular Therapy Division, Regina Margherita Children's Hospital, Torino, Italy.
Badino C; Pediatric Oncology Unit, IRCCS 'Istituto Giannina Gaslini,', Genova, Italy.
Botta D; Pediatric Unit, Ospedale Santissima Annunziata di Savigliano, Savigliano, Italy.
Fenicia D; Pediatric Hematology and Oncology Unit A.O.R.N, Santobono Pausilipon, Azienda Ospedaliera Pediatrica, Napoli, Italy.
Longo A; Pediatric Hematology and Oncology Unit, IRCCS Materno Infantile 'Burlo Garofolo,', Trieste, Italy.
Macchi S; Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.
Ricciardi C; Pediatric Hematology and Oncology Unit, IRCCS Ospedale 'Casa Sollievo della Sofferenza,', San Giovanni Rotondo, Italy.
Partel MC; Pediatric Hematology and Oncology Unit, Children's Hospital, ASST Spedali Civili di Brescia, Brescia, Italy.
Pokaż więcej
Źródło :
Pediatric blood & cancer [Pediatr Blood Cancer] 2020 Dec; Vol. 67 (12), pp. e28505. Date of Electronic Publication: 2020 Jun 26.
Typ publikacji :
Letter; Multicenter Study
MeSH Terms :
Betacoronavirus*
Coronavirus Infections/*prevention & control
Hematologic Diseases/*therapy
Neoplasms/*therapy
Pandemics/*prevention & control
Pneumonia, Viral/*prevention & control
COVID-19 ; Child ; Coronavirus Infections/epidemiology ; Coronavirus Infections/transmission ; Female ; Hematologic Diseases/epidemiology ; Humans ; Italy/epidemiology ; Male ; Neoplasms/epidemiology ; Pneumonia, Viral/epidemiology ; Pneumonia, Viral/transmission ; SARS-CoV-2
Raport
Tytuł :
Dose-volume parameters of MRI-based active bone marrow predict hematologic toxicity of chemoradiotherapy for rectal cancer.
Autorzy :
Kuncman Ł; Department of Radiotherapy, Medical University of Lodz, Zakład Radioterapii, W.W.C.O.iT. im. M. Kopernika w Łodzi, Pabianicka 62 street, 93-513, Łódź, Poland. .; Department of External Beam Radiotherapy, Regional Cancer Center, Copernicus Memorial Hospital of Lodz, Zakład Teleradioterapii, Wojewódzkie W.W.C.O.iT. im. M. Kopernika w Łodzi, Pabianicka 62 street, 93-513, Łódź, Poland. .
Stawiski K; Department of Biostatistics and Translational Medicine, Medical University of Lodz, Zakład Biostatystyki i Medycyny Translacyjnej, Cenrum Mazowiecka 15 street, 92-215, Łódź, Poland.
Masłowski M; Department of External Beam Radiotherapy, Regional Cancer Center, Copernicus Memorial Hospital of Lodz, Zakład Teleradioterapii, Wojewódzkie W.W.C.O.iT. im. M. Kopernika w Łodzi, Pabianicka 62 street, 93-513, Łódź, Poland.
Kucharz J; Department of Uro-Oncology, Maria Sklodowska-Curie Memorial Cancer Centre and Institute of Oncology Warsaw, Klinika Nowotworów Układu Moczowego, Centrum Onkologii-Instytut im. Marii Skłodowskiej-Curie ul. Roentgena 5, 02-781, Warszawa, Poland.
Fijuth J; Department of Radiotherapy, Medical University of Lodz, Zakład Radioterapii, W.W.C.O.iT. im. M. Kopernika w Łodzi, Pabianicka 62 street, 93-513, Łódź, Poland.; Department of External Beam Radiotherapy, Regional Cancer Center, Copernicus Memorial Hospital of Lodz, Zakład Teleradioterapii, Wojewódzkie W.W.C.O.iT. im. M. Kopernika w Łodzi, Pabianicka 62 street, 93-513, Łódź, Poland.
Pokaż więcej
Źródło :
Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] [Strahlenther Onkol] 2020 Nov; Vol. 196 (11), pp. 998-1005. Date of Electronic Publication: 2020 Jul 03.
Typ publikacji :
Journal Article
MeSH Terms :
Adenocarcinoma/*therapy
Bone Marrow/*drug effects
Bone Marrow/*radiation effects
Chemoradiotherapy/*adverse effects
Hematologic Diseases/*etiology
Magnetic Resonance Imaging/*methods
Neoadjuvant Therapy/*adverse effects
Radiotherapy, Conformal/*adverse effects
Rectal Neoplasms/*therapy
Adenocarcinoma/blood ; Adenocarcinoma/surgery ; Aged ; Antimetabolites, Antineoplastic/therapeutic use ; Bone Marrow/diagnostic imaging ; Combined Modality Therapy ; Dose-Response Relationship, Radiation ; Female ; Fluorouracil/therapeutic use ; Hematologic Diseases/chemically induced ; Humans ; Lymphocyte Count ; Male ; Middle Aged ; Platelet Count ; Predictive Value of Tests ; Prognosis ; Prospective Studies ; ROC Curve ; Radiotherapy Planning, Computer-Assisted ; Rectal Neoplasms/blood ; Rectal Neoplasms/surgery ; Sensitivity and Specificity ; Tomography, X-Ray Computed
Czasopismo naukowe
Tytuł :
Clinical outcomes and risk factors for severe COVID-19 in patients with haematological disorders receiving chemo- or immunotherapy.
Autorzy :
Fox TA; Department of Haematology, University College London NHS Foundation Trust, London, UK.; UCL Institute of Immunity and Transplantation, UCL, London, UK.
Troy-Barnes E; Department of Haematology, University College London NHS Foundation Trust, London, UK.
Kirkwood AA; CR UK & UCL Cancer Trials Centre, UCL Cancer Institute, UCL, London, UK.
Chan WY; Department of Haematology, University College London NHS Foundation Trust, London, UK.; Department of Haematology, UCL Cancer Institute, London, UK.
Day JW; Department of Haematology, University College London NHS Foundation Trust, London, UK.; UCL Institute of Immunity and Transplantation, UCL, London, UK.
Chavda SJ; Department of Haematology, University College London NHS Foundation Trust, London, UK.; Department of Haematology, UCL Cancer Institute, London, UK.
Kumar EA; Department of Haematology, University College London NHS Foundation Trust, London, UK.; Centre for Cancer Genomics and Computational Biology, Barts Cancer Institute, Queen Mary University of London, London, UK.
David K; Department of Clinical Virology, University College London NHS Foundation Trust, London, UK.
Tomkins O; Department of Haematology, University College London NHS Foundation Trust, London, UK.
Sanchez E; Department of Clinical Virology, University College London NHS Foundation Trust, London, UK.
Scully M; Department of Haematology, University College London NHS Foundation Trust, London, UK.; UCLH NIHR Biomedical Research Centre, London, UK.
Khwaja A; Department of Haematology, University College London NHS Foundation Trust, London, UK.; Department of Haematology, UCL Cancer Institute, London, UK.
Lambert J; Department of Haematology, University College London NHS Foundation Trust, London, UK.; UCLH NIHR Biomedical Research Centre, London, UK.
Singer M; UCLH NIHR Biomedical Research Centre, London, UK.; Bloomsbury Institute of Intensive Care Medicine, UCL, London, UK.
Roddie C; Department of Haematology, University College London NHS Foundation Trust, London, UK.; Department of Haematology, UCL Cancer Institute, London, UK.; UCLH NIHR Biomedical Research Centre, London, UK.
Morris EC; Department of Haematology, University College London NHS Foundation Trust, London, UK.; UCL Institute of Immunity and Transplantation, UCL, London, UK.; UCLH NIHR Biomedical Research Centre, London, UK.; Department Immunology, Royal Free London Hospitals NHS Foundation Trust, London, UK.
Yong KL; Department of Haematology, University College London NHS Foundation Trust, London, UK.; Department of Haematology, UCL Cancer Institute, London, UK.; UCLH NIHR Biomedical Research Centre, London, UK.
Thomson KJ; Department of Haematology, University College London NHS Foundation Trust, London, UK.; UCLH NIHR Biomedical Research Centre, London, UK.
Ardeshna KM; Department of Haematology, University College London NHS Foundation Trust, London, UK.; UCLH NIHR Biomedical Research Centre, London, UK.
Pokaż więcej
Źródło :
British journal of haematology [Br J Haematol] 2020 Oct; Vol. 191 (2), pp. 194-206. Date of Electronic Publication: 2020 Aug 12.
Typ publikacji :
Journal Article
MeSH Terms :
Immunotherapy*
Antineoplastic Agents/*therapeutic use
COVID-19/*complications
Hematologic Diseases/*complications
Adult ; African Continental Ancestry Group ; Age Factors ; Aged ; Aged, 80 and over ; Antineoplastic Agents/administration & dosage ; COVID-19/mortality ; COVID-19/therapy ; Comorbidity ; Cross Infection/complications ; Female ; Hematologic Diseases/drug therapy ; Hematologic Diseases/mortality ; Hematologic Diseases/therapy ; Hematopoietic Stem Cell Transplantation ; Humans ; Leukemia/complications ; Leukemia/drug therapy ; Leukemia/mortality ; London/epidemiology ; Lymphoma/complications ; Lymphoma/drug therapy ; Lymphoma/mortality ; Male ; Middle Aged ; Respiration, Artificial ; Retrospective Studies ; Risk Factors ; SARS-CoV-2 ; Thrombophilia/drug therapy ; Thrombophilia/etiology ; Treatment Outcome ; Young Adult
Czasopismo naukowe
Tytuł :
Hematogone Hyperplasia Masquerading as Acute Lymphoblastic Leukemia With Concurrent Hypercupremia.
Autorzy :
Naithani R; Division of Hematology and Bone Marrow Transplant.
Jeyaraman P; Division of Hematology and Bone Marrow Transplant.
Dayal N; Department of Lab Medicine, Max Super-Specialty Hospital, New Delhi, India.
Pokaż więcej
Źródło :
Journal of pediatric hematology/oncology [J Pediatr Hematol Oncol] 2020 Oct; Vol. 42 (7), pp. e670-e672.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Copper/*metabolism
Hematologic Diseases/*diagnosis
Hyperplasia/*diagnosis
Pancytopenia/*diagnosis
Precursor Cell Lymphoblastic Leukemia-Lymphoma/*diagnosis
Child ; Hematologic Diseases/complications ; Hematologic Diseases/metabolism ; Humans ; Hyperplasia/complications ; Hyperplasia/metabolism ; Male ; Pancytopenia/complications ; Pancytopenia/metabolism ; Precursor Cell Lymphoblastic Leukemia-Lymphoma/complications ; Precursor Cell Lymphoblastic Leukemia-Lymphoma/metabolism ; Prognosis
Czasopismo naukowe
Tytuł :
Pediatric patients with benign hematological diseases during the COVID-19 pandemic.
Autorzy :
Bayhan T; Department of Pediatric Hematology and Oncology, University of Health Sciences, Ankara City Hospital, Ankara, Turkey.
Şahin S; Department of Pediatric Hematology and Oncology, University of Health Sciences, Ankara City Hospital, Ankara, Turkey.
Çulha V; Department of Pediatric Hematology and Oncology, University of Health Sciences, Ankara City Hospital, Ankara, Turkey.
Özbek N; Department of Pediatric Hematology and Oncology, University of Health Sciences, Ankara City Hospital, Ankara, Turkey.
Yaralı N; Department of Pediatric Hematology and Oncology, Ankara Yıldırım Beyazıt University, Ankara City Hospital, Ankara, Turkey.
Pokaż więcej
Źródło :
Pediatric blood & cancer [Pediatr Blood Cancer] 2020 Sep; Vol. 67 (9), pp. e28595. Date of Electronic Publication: 2020 Jul 15.
Typ publikacji :
Letter
MeSH Terms :
Betacoronavirus*
Coronavirus Infections*/diagnosis
Coronavirus Infections*/epidemiology
Coronavirus Infections*/therapy
Hematologic Diseases*/diagnosis
Hematologic Diseases*/epidemiology
Hematologic Diseases*/therapy
Pandemics*
Pneumonia, Viral*/diagnosis
Pneumonia, Viral*/epidemiology
Pneumonia, Viral*/therapy
Adolescent ; Adult ; COVID-19 ; Child ; Child, Preschool ; Female ; Humans ; Infant ; Male ; SARS-CoV-2
Opinia redakcyjna
Tytuł :
COVID-19 disease in New York City pediatric hematology and oncology patients.
Autorzy :
Gampel B; Division of Pediatric Hematology, Oncology, and Stem Cell Transplantation, Department of Pediatrics, Columbia University Medical Center, New York, New York.
Troullioud Lucas AG; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York.
Broglie L; Division of Pediatric Hematology, Oncology, and Stem Cell Transplantation, Department of Pediatrics, Columbia University Medical Center, New York, New York.
Gartrell-Corrado RD; Division of Pediatric Hematology, Oncology, and Stem Cell Transplantation, Department of Pediatrics, Columbia University Medical Center, New York, New York.
Lee MT; Division of Pediatric Hematology, Oncology, and Stem Cell Transplantation, Department of Pediatrics, Columbia University Medical Center, New York, New York.
Levine J; Division of Pediatric Hematology and Oncology, Weill Cornell Medicine, New York, New York.
Orjuela-Grimm M; Division of Pediatric Hematology, Oncology, and Stem Cell Transplantation, Department of Pediatrics, Columbia University Medical Center, New York, New York.; Department of Epidemiology, Columbia University, New York, New York.
Satwani P; Division of Pediatric Hematology, Oncology, and Stem Cell Transplantation, Department of Pediatrics, Columbia University Medical Center, New York, New York.
Glade-Bender J; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York.
Roberts SS; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York.
Pokaż więcej
Źródło :
Pediatric blood & cancer [Pediatr Blood Cancer] 2020 Sep; Vol. 67 (9), pp. e28420. Date of Electronic Publication: 2020 Jun 26.
Typ publikacji :
Letter; Multicenter Study; Research Support, N.I.H., Extramural
MeSH Terms :
Betacoronavirus*
Coronavirus Infections*/diagnosis
Coronavirus Infections*/epidemiology
Coronavirus Infections*/therapy
Hematologic Diseases*/diagnosis
Hematologic Diseases*/epidemiology
Hematologic Diseases*/therapy
Neoplasms*/diagnosis
Neoplasms*/epidemiology
Neoplasms*/therapy
Pandemics*
Pneumonia, Viral*/diagnosis
Pneumonia, Viral*/epidemiology
Pneumonia, Viral*/therapy
Adolescent ; Adult ; COVID-19 ; Child ; Child, Preschool ; Female ; Humans ; Infant ; Male ; New York City/epidemiology ; Prevalence ; Retrospective Studies ; SARS-CoV-2 ; Sex Factors
Raport
Tytuł :
Hematological features of persons with COVID-19.
Autorzy :
Li Q; Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 430022, Wuhan, China. .
Cao Y; Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 430022, Wuhan, China.
Chen L; Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 430022, Wuhan, China.
Wu D; Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 430022, Wuhan, China.
Yu J; Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 430022, Wuhan, China.
Wang H; Department of Hematology, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
He W; Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 430022, Wuhan, China.
Chen L; Department of Hematology, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Dong F; Intensive Care Units of Wuhan Third Hospital, Tongren Hospital of Wuhan University, Wuhan, China.
Chen W; Key Laboratory for Molecular Diagnosis of Hubei Province, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Chen W; Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 430022, Wuhan, China.
Li L; Wuhan Jin-Yin-Tan Hospital, Wuhan, China.
Ran Q; Department of Hematology, General Hospital of Central Theater Command, PLA, 300700, Wuhan, China.
Liu Q; Medical Records Statistics Department of Wuhan Third Hospital, Tongren Hospital of Wuhan University, Wuhan, China.
Ren W; Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 430022, Wuhan, China.
Gao F; Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 430022, Wuhan, China.
Chen Z; Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 430022, Wuhan, China. .
Gale RP; Center for Hematology Research, Department of Immunology and Inflammation, Imperial College London, London, UK.
Hu Y; Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 430022, Wuhan, China. .
Pokaż więcej
Źródło :
Leukemia [Leukemia] 2020 Aug; Vol. 34 (8), pp. 2163-2172. Date of Electronic Publication: 2020 Jun 11.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Betacoronavirus/*isolation & purification
Biomarkers/*blood
Coronavirus Infections/*mortality
Hematologic Diseases/*blood
Mortality/*trends
Pneumonia, Viral/*mortality
Adult ; Aged ; Aged, 80 and over ; C-Reactive Protein/analysis ; COVID-19 ; Coronavirus Infections/blood ; Coronavirus Infections/complications ; Coronavirus Infections/diagnosis ; Female ; Fibrin Fibrinogen Degradation Products/analysis ; Follow-Up Studies ; Hematologic Diseases/diagnosis ; Hematologic Diseases/virology ; Humans ; L-Lactate Dehydrogenase/blood ; Lymphocyte Count ; Lymphocytes/metabolism ; Male ; Middle Aged ; Pandemics ; Pneumonia, Viral/blood ; Pneumonia, Viral/complications ; Pneumonia, Viral/diagnosis ; Prognosis ; SARS-CoV-2 ; Severity of Illness Index ; Survival Rate
Czasopismo naukowe
Tytuł :
Hematological Abnormalities and Malnutrition Mediate Pathway between Cancer and Outcomes in Ischemic Stroke Patients.
Autorzy :
Gon Y; Department of Neurology, Osaka University Graduate School of Medicine, Osaka, Japan; Department of Medical Statistics, Osaka City University Graduate School of Medicine, Osaka, Japan. Electronic address: .
Kabata D; Department of Medical Statistics, Osaka City University Graduate School of Medicine, Osaka, Japan. Electronic address: .
Kawano T; Department of Neurology, Osaka University Graduate School of Medicine, Osaka, Japan.
Kanki H; Department of Neurology, Osaka University Graduate School of Medicine, Osaka, Japan. Electronic address: .
Todo K; Department of Neurology, Osaka University Graduate School of Medicine, Osaka, Japan. Electronic address: .
Sasaki T; Department of Neurology, Osaka University Graduate School of Medicine, Osaka, Japan. Electronic address: .
Shintani A; Department of Medical Statistics, Osaka City University Graduate School of Medicine, Osaka, Japan.
Mochizuki H; Department of Neurology, Osaka University Graduate School of Medicine, Osaka, Japan. Electronic address: .
Pokaż więcej
Źródło :
Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association [J Stroke Cerebrovasc Dis] 2020 Aug; Vol. 29 (8), pp. 104943. Date of Electronic Publication: 2020 Jun 05.
Typ publikacji :
Journal Article
MeSH Terms :
Disability Evaluation*
Hematologic Tests*
Nutrition Assessment*
Nutritional Status*
Biomarkers/*blood
Brain Ischemia/*diagnosis
Hematologic Diseases/*diagnosis
Malnutrition/*diagnosis
Neoplasms/*diagnosis
Stroke/*diagnosis
Aged ; Blood Platelets ; Brain Ischemia/epidemiology ; Brain Ischemia/therapy ; C-Reactive Protein/analysis ; Comorbidity ; Female ; Fibrin Fibrinogen Degradation Products/analysis ; Hematologic Diseases/blood ; Hematologic Diseases/epidemiology ; Hematologic Diseases/therapy ; Hemoglobins/analysis ; Humans ; Japan/epidemiology ; Male ; Malnutrition/epidemiology ; Malnutrition/physiopathology ; Malnutrition/therapy ; Middle Aged ; Neoplasms/epidemiology ; Neoplasms/therapy ; Predictive Value of Tests ; Prognosis ; Retrospective Studies ; Risk Assessment ; Risk Factors ; Stroke/epidemiology ; Stroke/therapy
Czasopismo naukowe
Tytuł :
COVID-19 in Children With Blood and Cancer Disorders: What Do We Know So Far?
Autorzy :
Yadav SP; Pediatric Hematology Oncology and Bone Marrow Transplant Unit, Cancer Institute Medanta The Medicity Hospital, Gurgaon Haryana, India.
Pokaż więcej
Źródło :
Journal of pediatric hematology/oncology [J Pediatr Hematol Oncol] 2020 Aug; Vol. 42 (6), pp. 413-414.
Typ publikacji :
Journal Article
MeSH Terms :
Coronavirus Infections/*epidemiology
Hematologic Diseases/*epidemiology
Hematologic Diseases/*virology
Neoplasms/*epidemiology
Neoplasms/*virology
Pneumonia, Viral/*epidemiology
Betacoronavirus/isolation & purification ; COVID-19 ; Child ; China/epidemiology ; Coronavirus Infections/therapy ; Hematologic Diseases/therapy ; Humans ; Neoplasms/therapy ; New York/epidemiology ; Pandemics ; Pneumonia, Viral/therapy ; SARS-CoV-2
Czasopismo naukowe
Tytuł :
Hypoglycemia and Dandy-Walker variant in a Kabuki syndrome patient: a case report.
Autorzy :
Guo W; Department of Neonatology, Xingtai People's Hospital, Xingtai, 054031, Hebei, China. .
Zhao Y; Department of Neonatology, Xingtai People's Hospital, Xingtai, 054031, Hebei, China.
Li S; Department of Neonatology, Xingtai People's Hospital, Xingtai, 054031, Hebei, China.
Wang J; Department of Neonatology, Xingtai People's Hospital, Xingtai, 054031, Hebei, China.
Liu X; Department of Neonatology, Xingtai People's Hospital, Xingtai, 054031, Hebei, China.
Pokaż więcej
Źródło :
BMC medical genetics [BMC Med Genet] 2020 Oct 02; Vol. 21 (1), pp. 193. Date of Electronic Publication: 2020 Oct 02.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Sequence Deletion*
Abnormalities, Multiple/*genetics
DNA-Binding Proteins/*genetics
Dandy-Walker Syndrome/*genetics
Face/*abnormalities
Hematologic Diseases/*genetics
Hypoglycemia/*genetics
Neoplasm Proteins/*genetics
Vestibular Diseases/*genetics
Abnormalities, Multiple/diagnosis ; Base Sequence ; Dandy-Walker Syndrome/diagnosis ; Female ; Genetic Testing ; Hematologic Diseases/diagnosis ; Humans ; Hypoglycemia/diagnosis ; Infant, Newborn ; Sequence Homology, Nucleic Acid ; Vestibular Diseases/diagnosis ; Whole Exome Sequencing/methods
SCR Disease Name :
Dandy Walker variant; Kabuki syndrome
Czasopismo naukowe
Tytuł :
In vitro maturation is a viable option for urgent fertility preservation in young women with hematological conditions.
Autorzy :
Sonigo C; Department of Reproductive Medicine and Fertility Preservation, Hôpital Jean Verdier, Hôpitaux Universitaires Paris-Seine-Saint-Denis, Assistance Publique - Hôpitaux de Paris, Bondy, France.; Inserm U1185 Université Paris-Sud, Université Paris Saclay, Le Kremlin Bicêtre, France.
Bajeux J; Department of Reproductive Medicine and Fertility Preservation, Hôpital Jean Verdier, Hôpitaux Universitaires Paris-Seine-Saint-Denis, Assistance Publique - Hôpitaux de Paris, Bondy, France.
Boubaya M; Département de recherche clinique, Groupe Hospitalier Paris Seine Saint Denis, Assistance Publique -Hôpitaux de Paris, Université Paris 13, Bobigny et INSERM U1153, Paris, France.
Eustache F; Department of Cytogenetic and Reproductive Biology, Hôpital Jean Verdier, Hôpitaux Universitaires Paris-Seine-Saint-Denis, Assistance Publique - Hôpitaux de Paris, Bondy, France.
Sifer C; Department of Cytogenetic and Reproductive Biology, Hôpital Jean Verdier, Hôpitaux Universitaires Paris-Seine-Saint-Denis, Assistance Publique - Hôpitaux de Paris, Bondy, France.
Lévy V; Département de recherche clinique, Groupe Hospitalier Paris Seine Saint Denis, Assistance Publique -Hôpitaux de Paris, Université Paris 13, Bobigny et INSERM U1153, Paris, France.
Grynberg M; Department of Reproductive Medicine and Fertility Preservation, Hôpital Jean Verdier, Hôpitaux Universitaires Paris-Seine-Saint-Denis, Assistance Publique - Hôpitaux de Paris, Bondy, France.; Inserm U1185 Université Paris-Sud, Université Paris Saclay, Le Kremlin Bicêtre, France.; Unité de Formation et de Recherche Santé Médecine et Biologie Humaine, Université Paris 13, Communauté d'Universités et Etablissements Sorbonne Paris Cité, Paris, France Inserm U1133 Université Paris Diderot, Paris, France.
Sermondade N; Department of Cytogenetic and Reproductive Biology, Hôpital Jean Verdier, Hôpitaux Universitaires Paris-Seine-Saint-Denis, Assistance Publique - Hôpitaux de Paris, Bondy, France.
Pokaż więcej
Źródło :
Hematological oncology [Hematol Oncol] 2020 Oct; Vol. 38 (4), pp. 560-564. Date of Electronic Publication: 2020 Mar 03.
Typ publikacji :
Journal Article
MeSH Terms :
Cryopreservation/*methods
Fertility Preservation/*methods
Hematologic Diseases/*therapy
In Vitro Oocyte Maturation Techniques/*methods
Oocyte Retrieval/*methods
Adult ; Female ; Follow-Up Studies ; Hematologic Diseases/physiopathology ; Humans ; Prognosis ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Hematological toxicities in immune checkpoint inhibitors: A pharmacovigilance study from 2014 to 2019.
Autorzy :
Ye X; Department of Health Statistics, Second Military Medical University, Shanghai, China.
Hu F; Department of Health Statistics, Second Military Medical University, Shanghai, China.
Zhai Y; Department of Health Statistics, Second Military Medical University, Shanghai, China.; Tongji University School of Medicine, Shanghai, China.
Qin Y; Department of Health Statistics, Second Military Medical University, Shanghai, China.
Xu J; Department of Health Statistics, Second Military Medical University, Shanghai, China.
Guo X; Department of Health Statistics, Second Military Medical University, Shanghai, China.
Zhuang Y; Beijing Bioknow Information Technology Co.Ltd., Beijing, China.
He J; Department of Health Statistics, Second Military Medical University, Shanghai, China.; Tongji University School of Medicine, Shanghai, China.
Pokaż więcej
Źródło :
Hematological oncology [Hematol Oncol] 2020 Oct; Vol. 38 (4), pp. 565-575. Date of Electronic Publication: 2020 Jun 09.
Typ publikacji :
Journal Article
MeSH Terms :
Databases, Factual*
Antineoplastic Agents, Immunological/*adverse effects
Hematologic Diseases/*chemically induced
Immunotherapy/*adverse effects
Neoplasms/*drug therapy
Aged ; Female ; Follow-Up Studies ; Hematologic Diseases/pathology ; Humans ; Male ; Neoplasms/immunology ; Neoplasms/pathology ; Pharmacovigilance ; Prognosis ; Retrospective Studies ; Survival Rate ; Time Factors
Czasopismo naukowe
Tytuł :
[The Chinese guidelines for the diagnosis and treatment of invasive fungal disease in patients with hematological disorders and cancers (the 6th revision)].
Corporate Authors :
Chinese Association Hematologists
Chinese Invasive Fungal Infection Working Group
Źródło :
Zhonghua nei ke za zhi [Zhonghua Nei Ke Za Zhi] 2020 Oct 01; Vol. 59 (10), pp. 754-763.
Typ publikacji :
Journal Article; Practice Guideline
MeSH Terms :
Invasive Fungal Infections*/diagnosis
Invasive Fungal Infections*/drug therapy
Mycoses*/diagnosis
Mycoses*/drug therapy
Hematologic Diseases/*microbiology
Neoplasms/*microbiology
Antifungal Agents/therapeutic use ; China ; Hematologic Diseases/complications ; Humans ; Neoplasms/complications ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Peripherally Inserted Central Venous Catheter for Pediatric and Young Adult Patients With Hematologic and Malignant Diseases.
Autorzy :
Suzuki D; Department of Hematology/Oncology for Children and Adolescents, Sapporo Hokuyu Hospital, Sapporo, Japan.
Kobayashi R
Sano H
Yanagi M
Hori D
Matsushima S
Nakano T
Kobayashi K
Pokaż więcej
Źródło :
Journal of pediatric hematology/oncology [J Pediatr Hematol Oncol] 2020 Oct; Vol. 42 (7), pp. 429-432.
Typ publikacji :
Journal Article
MeSH Terms :
Catheter-Related Infections/*etiology
Catheterization, Central Venous/*adverse effects
Catheterization, Peripheral/*adverse effects
Central Venous Catheters/*adverse effects
Hematologic Diseases/*therapy
Adolescent ; Adult ; Catheter-Related Infections/pathology ; Child ; Child, Preschool ; Female ; Follow-Up Studies ; Hematologic Diseases/pathology ; Humans ; Infant ; Infant, Newborn ; Male ; Prognosis ; Retrospective Studies ; Risk Factors ; Young Adult
Czasopismo naukowe
Tytuł :
COVID-19 in benign hematology: emerging challenges and special considerations for healthcare professionals.
Autorzy :
Noun P; Division of Pediatric Hematology-Oncology, Saint George Hospital University Medical Center , Beirut, Lebanon.
Ibrahim A; Division of Hematology and Oncology, Department of Internal Medicine, Makassed General Hospital , Beirut, Lebanon.; Middle East Institute of Health, Lebanese University , Beirut, Lebanon.
Hodroj MH; Department of Internal Medicine, American University of Beirut Medical Center , Beirut, Lebanon.
Bou-Fakhredin R; Division of Hematology and Oncology, Department of Internal Medicine, American University of Beirut Medical Center , Beirut, Lebanon.
Taher AT; Division of Hematology and Oncology, Department of Internal Medicine, American University of Beirut Medical Center , Beirut, Lebanon.
Pokaż więcej
Źródło :
Expert review of hematology [Expert Rev Hematol] 2020 Oct; Vol. 13 (10), pp. 1081-1092. Date of Electronic Publication: 2020 Sep 15.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Coronavirus Infections/*complications
Hematologic Diseases/*complications
Pneumonia, Viral/*complications
Betacoronavirus/isolation & purification ; COVID-19 ; Coronavirus Infections/epidemiology ; Coronavirus Infections/therapy ; Disease Management ; Health Personnel ; Hematologic Diseases/therapy ; Humans ; Pandemics ; Pneumonia, Viral/epidemiology ; Pneumonia, Viral/therapy ; SARS-CoV-2
Czasopismo naukowe
Tytuł :
Clinical characteristics and outcome of SARS-CoV-2-infected patients with haematological diseases: a retrospective case study in four hospitals in Italy, Spain and the Netherlands.
Autorzy :
van Doesum J; Department of Hematology, University Medical Center Groningen, Groningen, The Netherlands. .
Chinea A; Department of Hematology, Hospital Ramón y Cajal, Madrid, Spain.
Pagliaro M; Hematology Unit, San Giovanni Bosco General Hospital, Torino, Italy.
Pasquini MC; Oncology Unit, ASST of Crema, Crema, Italy.
van Meerten T; Department of Hematology, University Medical Center Groningen, Groningen, The Netherlands.
Bakker M; Department of Hematology, University Medical Center Groningen, Groningen, The Netherlands.
Ammatuna E; Department of Hematology, University Medical Center Groningen, Groningen, The Netherlands.
Pokaż więcej
Źródło :
Leukemia [Leukemia] 2020 Sep; Vol. 34 (9), pp. 2536-2538. Date of Electronic Publication: 2020 Jul 08.
Typ publikacji :
Letter; Comment
MeSH Terms :
Coronavirus Infections*
Hematologic Diseases*
Hematologic Neoplasms*
Pandemics*
Pneumonia, Viral*
Betacoronavirus ; COVID-19 ; Humans ; Italy ; Netherlands ; Retrospective Studies ; SARS-CoV-2 ; Spain
Opinia redakcyjna

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies